SCHEMBL10132273

SCHEMBL10132273

CC(C)(C)OC(=O)N1CCC[C@H]1Cc1cccc(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.49
RIPK1 Q13546 1/20 0.49
NR1H2 P55055 2/20 0.47
NR1H3 Q13133 2/20 0.47
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
APP P05067 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
SLC6A2 P23975 1/20 0.45
HRH2 P25021 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR7 P34969 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20828162 0.97 GPR119 (0.48) GPR119RIPK1NR1H2NR1H3MAPT
SCHEMBL13832734 0.89 GPR119 (0.48) GPR119RIPK1NR1H2NR1H3MAPT
SCHEMBL28030599 0.89 GPR119 (0.48) GPR119RIPK1NR1H2NR1H3MAPT
SCHEMBL15684527 0.89 GPR119 (0.48) GPR119RIPK1NR1H2NR1H3MAPT
SCHEMBL10132498 0.87 NR1H2 (0.48) NR1H2NR1H3MAPTNPSR1DAGLA
SCHEMBL10132519 0.87 HRH3 (0.52) NR1H2NR1H3MAPTNPSR1ABHD6
SCHEMBL14940096 0.86 NR1H2 (0.47) NR1H2NR1H3MAPTNPSR1ALOX5AP
SCHEMBL14940097 0.86 NR1H2 (0.47) NR1H2NR1H3MAPTNPSR1ALOX5AP
SCHEMBL10132370 0.86 ALDH1A1 (0.50) NR1H2NR1H3MAPTNPSR1DPP4
SCHEMBL23478097 0.86 CCR3 (0.47) NR1H2NR1H3APPHTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374794-B1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2015-11-04 EP disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-2374794-A1 CYCLIC AMINE COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 EP disclosed
WO-2010074088-A1 CYCLIC AMINE COMPOUNDS 第一三共株式会社 (JP) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319468-A1 CYCLIC AMINE COMPOUNDS RYR2, CASR, RYR1 GPR119 151/4885RIPK1 2482/4885NR1H2 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.